These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9331215

  • 1. A comparative study of two dose regimens of latanoprost in patients with elevated intraocular pressure.
    Lusky M, Ticho U, Glovinsky J, Weinberger D, Nesher R, Yassur Y, Melamed S.
    Ophthalmology; 1997 Oct; 104(10):1720-4. PubMed ID: 9331215
    [Abstract] [Full Text] [Related]

  • 2. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
    Mishima HK, Masuda K, Kitazawa Y, Azuma I, Araie M.
    Arch Ophthalmol; 1996 Aug; 114(8):929-32. PubMed ID: 8694726
    [Abstract] [Full Text] [Related]

  • 3. First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure.
    Denis P, Baudouin C, Bron A, Nordmann JP, Renard JP, Rouland JF, Sellem E, Amrane M.
    BMC Ophthalmol; 2010 Feb 24; 10():4. PubMed ID: 20181282
    [Abstract] [Full Text] [Related]

  • 4. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH, Greve EL, Geijssen HC, Hoyng PF.
    Ophthalmology; 1996 Aug 24; 103(8):1276-82. PubMed ID: 8764799
    [Abstract] [Full Text] [Related]

  • 5. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
    Camras CB.
    Ophthalmology; 1996 Jan 24; 103(1):138-47. PubMed ID: 8628544
    [Abstract] [Full Text] [Related]

  • 6. Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension.
    Harasymowycz P, Hutnik CM, Nicolela M, Stewart WC.
    Can J Ophthalmol; 2007 Feb 24; 42(1):75-81. PubMed ID: 17361245
    [Abstract] [Full Text] [Related]

  • 7. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T, Chew PT, Yip CC, Chan YH, See JL, Khng CG, Hoh ST, Ng LH, Lee HM.
    Am J Ophthalmol; 2001 May 24; 131(5):636-42. PubMed ID: 11336940
    [Abstract] [Full Text] [Related]

  • 8. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM, McGavin JK, Culy CR, Ibbotson T.
    Drugs Aging; 2003 May 24; 20(8):597-630. PubMed ID: 12795627
    [Abstract] [Full Text] [Related]

  • 9. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH, Greve EL, Hoyng PF.
    Ophthalmology; 1997 Sep 24; 104(9):1503-7. PubMed ID: 9307648
    [Abstract] [Full Text] [Related]

  • 10. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA, Raber S, Courtney R, Zhang M.
    Curr Eye Res; 2011 Sep 24; 36(9):809-17. PubMed ID: 21851167
    [Abstract] [Full Text] [Related]

  • 11. Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure.
    Bacharach J, Dubiner HB, Levy B, Kopczynski CC, Novack GD, AR-13324-CS202 Study Group.
    Ophthalmology; 2015 Feb 24; 122(2):302-7. PubMed ID: 25270273
    [Abstract] [Full Text] [Related]

  • 12. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
    Watson P, Stjernschantz J.
    Ophthalmology; 1996 Jan 24; 103(1):126-37. PubMed ID: 8628543
    [Abstract] [Full Text] [Related]

  • 13. A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study.
    Weinreb RN, Ong T, Scassellati Sforzolini B, Vittitow JL, Singh K, Kaufman PL, VOYAGER study group.
    Br J Ophthalmol; 2015 Jun 24; 99(6):738-45. PubMed ID: 25488946
    [Abstract] [Full Text] [Related]

  • 14. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
    Rácz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ.
    Arch Ophthalmol; 1996 Mar 24; 114(3):268-73. PubMed ID: 8600885
    [Abstract] [Full Text] [Related]

  • 15. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.
    Susanna R, Giampani J, Borges AS, Vessani RM, Jordao ML.
    Ophthalmology; 2001 Feb 24; 108(2):259-63. PubMed ID: 11158796
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
    Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE.
    Am J Ophthalmol; 2001 May 24; 131(5):631-5. PubMed ID: 11336939
    [Abstract] [Full Text] [Related]

  • 17. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA, Cimino L.
    Ophthalmology; 2003 Mar 24; 110(3):609-14. PubMed ID: 12623831
    [Abstract] [Full Text] [Related]

  • 18. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
    Diestelhorst M, Larsson LI, European Latanoprost Fixed Combination Study Group.
    Br J Ophthalmol; 2004 Feb 24; 88(2):199-203. PubMed ID: 14736774
    [Abstract] [Full Text] [Related]

  • 19. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS, United States Fixed-Combination Study Group.
    Arch Ophthalmol; 2010 Feb 24; 128(2):165-72. PubMed ID: 20142538
    [Abstract] [Full Text] [Related]

  • 20. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
    Liu CJ, Ko YC, Cheng CY, Chiu AW, Chou JC, Hsu WM, Liu JH.
    Ophthalmology; 2002 Dec 24; 109(12):2241-7. PubMed ID: 12466165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.